Clinical Trial Update: Stem Cell Study for Patients With Heart Disease [Phase 1, Phase 2]

View source ↗

Summary

The stem cell therapy trial for heart disease in Phase 1/Phase 2 has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: Foundation for Biomedical Research and Innovation | Conditions: Chest Pain, Chronic Myocardial Ischemia | Phase 1, Phase 2 | Status: TERMINATED